CLINICAL_TRIALS
trial_result
· 2018-04-13
Clinical Trial Update: A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy [Phase 4]
Summary
A Phase 4 study evaluating intravenous immunoglobulin for HIV-associated myelopathy was terminated, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David M. Simpson | Conditions: HIV-associated Myelopathy | Phase 4 | Status: TERMINATED | Results posted: 2018-04-13